Jyothy Labs Limited
1,513words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
Complex, Bandra – (East). Mumbai - 400051 Scrip Code: JYOTHYLAB BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400023 Scrip Code: 532926 Dear Sirs, Sub: Analyst Meet Presentation With refe
50%
MP Ramachandran. •Jyothy Labs is primarily in Home Care and Personal Care segments which constitute 50% of the Indian FMCG industry.Fabric CareKey Product CategoriesDish WashHousehold InsecticidesPersona
Rs 1900
ustry.Fabric CareKey Product CategoriesDish WashHousehold InsecticidesPersonal CareOur Power Brands~Rs 1900+ crRevenue in FY 20212.8 Mn Outlets –Pan India availability0.86 mnDirect Reach23 Manufacturing Plan
rs7200
8 Mn Outlets –Pan India availability0.86 mnDirect Reach23 Manufacturing Plants2400+ Sales team members7200+ Channel Partners (Distributor’s -1600, Sub-Stockists for Rural Areas -5600)# 1 –In Fabric Whitener
RS7
line Channel continues to see good traction6 WE ARE ON ACCELERATED GROWTH PLANS --OUR STRATEGIC LEVERS7#1 Distribution #5 Sustainability#2 Brand Investment #4 Innovation#3 Digital TechnologyHiring of Se
100%
etailer App for direct deliveryIncreased visibility across all E-com platformTshinefloor cleaner -100% Organic Compound basedExo BiohFresh –100% organic Vegetable and Fruit CleanerExo All Surface Clea
26%
ed on Company’s unaudited MIS growth over same period previous yearSales GrowthJan-March’21April’21*26%Double Digit GrowthOUR JOURNEY FOR THE LAST 12 MONTHS….Sales Growth11.6%EBITDA Growth EBITDA Margin2
11.6%
es GrowthJan-March’21April’21*26%Double Digit GrowthOUR JOURNEY FOR THE LAST 12 MONTHS….Sales Growth11.6%EBITDA Growth EBITDA Margin25.3%16.5% vs guidance of 15-16%Net Debt FreeStrict Business HygieneSIGNI
25.3%
%Double Digit GrowthOUR JOURNEY FOR THE LAST 12 MONTHS….Sales Growth11.6%EBITDA Growth EBITDA Margin25.3%16.5% vs guidance of 15-16%Net Debt FreeStrict Business HygieneSIGNIFICANT MARKET SHARE GAINS!!!!CY
16.5%
le Digit GrowthOUR JOURNEY FOR THE LAST 12 MONTHS….Sales Growth11.6%EBITDA Growth EBITDA Margin25.3%16.5% vs guidance of 15-16%Net Debt FreeStrict Business HygieneSIGNIFICANT MARKET SHARE GAINS!!!!CY 20 *E
16%
EY FOR THE LAST 12 MONTHS….Sales Growth11.6%EBITDA Growth EBITDA Margin25.3%16.5% vs guidance of 15-16%Net Debt FreeStrict Business HygieneSIGNIFICANT MARKET SHARE GAINS!!!!CY 20 *Exo BarPril12.5%17.4 %M
12.5%
ce of 15-16%Net Debt FreeStrict Business HygieneSIGNIFICANT MARKET SHARE GAINS!!!!CY 20 *Exo BarPril12.5%17.4 %Maxo -CoilMaxo -LVMS Gain over CY19Ujala FBUjalaIDD **120bps20.7%82.6%8.8%22.9 %130bps170bps40
Advertisement